Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Soc Psychiatry Psychiatr Epidemiol ; 58(6): 919-929, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36526939

ABSTRACT

PURPOSE: The aim of this study is to evaluate the prevalence of anxiety disorders, its correlation with sociodemographic characteristics, its comorbidities with other psychiatric disorders and its predictors in school-aged children. METHODS: This study is part of a representative, multi-centered national study that is planned by the Turkish Association of Child and Adolescent Mental Health to evaluate the prevalence of psychopathology among elementary school students in Turkey between the years 2014-2015. Children are screened via Kiddie Schedule for Affective Disorders and Schizophrenia for School Age Children Present and Lifetime Version. Impairment is assessed by a 3-point Likert type scale independently by the parent and the teacher. The final sample included 5842 children with the mean age of 8.7 years. RESULTS: The prevalence of any anxiety disorder without considering impairment is 16.7% and considering impairment is 5.2% in children according to our study. We found significant differences for comorbid Attention Deficit Hyperactivity Disorder, Disruptive Behavior Disorder, Mood Disorders, Tic Disorders, Obsessive Compulsive Disorder, Enuresis Nocturna, Encopresis, and Intellectual Disability. Having a history of paternal physical disorder, living in the regions of Marmara, Mediterranean and Black Sea were found to be the main predictors of having childhood anxiety disorders according to the logistic regression analysis. CONCLUSION: Better understanding of childhood anxiety disorders, comorbid conditions and predictors will result in earlier diagnosis and more appropriate treatment.


Subject(s)
Anxiety Disorders , Attention Deficit Disorder with Hyperactivity , Child , Adolescent , Humans , Prevalence , Turkey/epidemiology , Anxiety Disorders/psychology , Mood Disorders/epidemiology , Comorbidity , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/epidemiology , Attention Deficit Disorder with Hyperactivity/psychology , Epidemiologic Studies
2.
Eur Rev Med Pharmacol Sci ; 17(17): 2345-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24065228

ABSTRACT

BACKGROUND: Switching from Immediate Release Methylphenidate (MPH-IR) to a sustained release formulation in treatment of attention deficit/hyperactivity disorder (ADHD) is often required to provide better compliance and convenience. However; the switch has been reported to be not always successful and small doses of MPH-IR may be added to sustained release preparations when its effect wears off. SUBJECTS AND METHODS: In this survey, clinical case notes of 77 subjects aged 6-18 years who had been switched from MPH-IR to Concerta XL were retrospectively analyzed to demonstrate the effectiveness of the switch. The impact of adding MPH-IR to Concerta XL on the outcome was evaluated. RESULTS: Switch to Concerta XL alone was successful in 94% of cases and all 23 (100%) subjects who had MPH-IR added to Concerta XL showed good response to the switch. However; more than 43% of the subjects required additional doses of MPH-IR and 55% needed a larger than recommended equivalent doses of Concerta XL for a successful switch. CONCLUSIONS: Higher than equivalent doses of Concerta XL or an additional dose of MPH-IR may be required for a successful switch from immediate to sustained release methylphenidate.


Subject(s)
Attention Deficit Disorder with Hyperactivity/drug therapy , Central Nervous System Stimulants/therapeutic use , Methylphenidate/therapeutic use , Adolescent , Central Nervous System Stimulants/administration & dosage , Child , Delayed-Action Preparations , Dose-Response Relationship, Drug , Female , Humans , Male , Methylphenidate/administration & dosage , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...